Leading the Fight to treat and cure
Tay-Sachs, Canavan, Sandhoff, GM1 and related diseases

Folder Press Releases


pdf 2018 Dec 13 Press Release Axovant Licenses GM2 and GM1 Gene Therapies Popular


Download (pdf, 93 KB)

2018 Dec 13 Press Release Axovant Licenses GM2 and GM1 Gene Therapies.pdf

pdf NTSAD Announces Research Initiative Grant Recipients Popular


Download (pdf, 426 KB)

NTSAD_2015 Research Grants final corrected.pdf

National Tay-Sachs & Allied Diseases Announces Research Initiative Grant Recipients

Nation’s first patient advocacy organization awards five grants totaling $266,000

September 18, 2015—BOSTON, MA—National Tay-Sachs & Allied Diseases Association (NTSAD), the nation’s first patient advocacy organization, today announced the awardees of its 2015 Innovative Research Grants. Reflecting an ongoing commitment to fund research aligned with its mission to lead the fight to treat and cure Tay-Sachs (TSD), GM-1, Sandhoff, Canavan (CD) and other related genetic diseases, NTSAD has solicited proposals for basic, translational or clinical research projects. This year’s grants include projects related to newborn screening, gene therapy delivery methods, animal models and international patient registries.

Read more by selecting the .pdf

pdf NTSAD Corporate Advisory Council Announcement Popular


Download (pdf, 329 KB)



Enter your email to receive NTSAD's email newsletters.